CLINICAL_TRIALS
trial_result
· 2020-11-17
Clinical Trial Update: Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia [Phase 2]
Summary
Phase II study of bexarotene in Acute Myeloid Leukemia was terminated; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2020-11-17